Canada· CA-DIN-02454548
GRASTOFIL
A filgrastim product containing filgrastim, registered in Canada by APOTEX INC. The same ATC class is registered in 17 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Filgrastim is registered in 17 of 19 countries.
Countries holding a registration under ATC L03AA02 (filgrastim), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 10 of them publish a price we can compare per daily dose
Filgrastim · ATC L03AA02
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- FILGRASTIM
- Manufacturer
- APOTEX INC
- Country
- Canada (CA)
- ATC code
- L03AA02
- ATC class
- Filgrastim
- Defined daily dose
- 0.35 mg, P
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
191 interactions on record for filgrastim.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Filgrastim · interactions on record
191 records
- 2 severe
- 189 moderate
Most severe, free to view
- CladribineL01BB04severe
- CyclophosphamideL01AA01moderate
- ChlorambucilL01AA02moderate
- MelphalanL01AA03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Filgrastim in 18 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaACCOFILAccord Healthcare S.L.U., Barcelona
- FinlandAccofilAccord Healthcare S.L.U.
- United StatesFILKRIAccord BioPharma Inc.,
- SpainACCOFIL 12 MU/0,2 ML SOLUCION INYECTABLE Y PARA PERFUSION EN JERINGA PRECARGADAAccord Healthcare S.L.U.
- BelgiumAccofil 12 10*6 U/0.2 mlAccord Healthcare
- PolandAccofilAccord Healthcare S.L.U.
- IrelandAccofil 30 MU/0.5 ml solution for injection/infusion in pre-filled syringeAccord Healthcare S.L.U.
- FranceACCOFIL 12 MU/0,2 ml, solution injectable ou pour perfusion en seringue préremplieACCORD HEALTHCARE (ESPAGNE)
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Belgium · Neupogen
- Germany · Neupogen
- Spain · Neupogen
- France · Neupogen
- United Kingdom (Northern Ireland) · Neupogen, Neupogen Singleject
- Ireland · Neupogen, Neupogen Singleject
- Iceland · Accofil, Filgrastim Hexal
- Italy · Granulokine
- Liechtenstein · Accofil, Filgrastim Hexal
- Luxembourg · Neupogen
- Netherlands · Neupogen, Neupogen Singleject
- Norway · Accofil, Filgrastim Hexal
- Poland · Neupogen
- Sweden · Neupogen
- Slovenia · Neupogen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e6720367-5319-4d5f-b088-79e5ddb49dbf GET /v1/drugs/e6720367-5319-4d5f-b088-79e5ddb49dbf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02454548",
"form": "SOLUTION",
"class": "Human",
"routes": [
"INTRAVENOUS",
"SUBCUTANEOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "L03AA02",
"schedule": [
"Prescription",
"Schedule D"
],
"drug_code": "94117",
"strengths": [
"480 MCG"
],
"ahfs_class": null,
"substances": [
"FILGRASTIM"
],
"product_categorization": null
}See everything about filgrastim.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.